top of page

SCAN

Science + Clinical Care for Autism and Neurodevelopmental Conditions is a community of practice and journal club for clinicians focused on integrating the latest scientific evidence into clinical care for individuals with autism and neurodevelopmental conditions across the lifespan.

March 20 - 2026

SCAN Journal Club Session
Details coming soon.




 

December 19 - 2025

SCAN Journal Club Session
Details coming soon.



 

February 20 - 2026

SCAN Journal Club Session
Details coming soon.




 

November 21 - 2025

SCAN Journal Club Session
Details coming soon.



 

January 16 - 2025

A Randomized, Placebo-Controlled Trial of Metformin for the Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorder: Open-Label Extension

Territorial Acknowledgement 

PRISMA respectfully acknowledges that Alberta is located on Treaty 4, 6, 7, and 8 Territory traditional lands - a traditional gathering place for diverse Indigenous peoples, including the Cree, Blackfoot, Métis, Dene, Stoney-Nakoda Sioux, Saulteaux, Siksika, the Pikuni, the Kainai, the Tsuut’ina, the Stoney-Nakoda First Nations and many others whose histories, languages and cultures continue to influence our vibrant community.

Our Collaborators

University of Alberta Logo - PRISMA Collaborator
Casa Mental Health Logo - PRISMA Collaborator
Recovery Alberta Logo - PRISMA Collaborator

Contact us:

prisma@ualberta.ca

11361 87th Ave - Suite 5-020K

University of Alberta

  • PRISMA Research Group Linkedin
  • Instagram
  • Facebook
  • YouTube

© 2026 PRISMA – Precision Medicine in Autism. All Rights Reserved. | In affiliation with the University of Alberta | Privacy Policy | Terms of Use

bottom of page